Published in J Immunol on January 01, 1983
Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms. J Clin Invest (1986) 2.47
Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J Exp Med (1983) 1.74
Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease. J Exp Med (1990) 1.47
The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice. J Exp Med (1987) 1.39
Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol (1990) 1.05
Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med (2006) 1.02
Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease. Clin Exp Immunol (1990) 0.97
Specificity of anti-nuclear antibodies induced in F1 mice undergoing the graft-vs-host reaction: isotypes and cross-reactivities. Clin Exp Immunol (1987) 0.92
Advances in lupus stemming from the parent-into-F1 model. Trends Immunol (2010) 0.90
Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E). Clin Exp Immunol (1986) 0.89
CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody. Immunology (2003) 0.88
Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression. Clin Immunol (2010) 0.87
Suppression of spontaneous murine lupus by inducing graft-versus-host reaction with CD8+ cells. Clin Exp Immunol (1992) 0.87
Cell-mediated pathology during murine malaria-associated nephritis. Clin Exp Immunol (1993) 0.82
Genetics of experimental lupus nephritis: non-H-2 factors determine susceptibility for renal involvement in murine chronic graft-versus-host disease. Clin Exp Immunol (1989) 0.82
A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Am J Pathol (1992) 0.81
Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development. Clin Exp Immunol (1989) 0.80
Autoimmune disease after neonatal injection of semi-allogeneic spleen cells in mice: involvement of donor B and T cells and characterization of glomerular deposits. Clin Exp Immunol (1987) 0.80
Fine specificities of anti-nuclear antibodies in murine models of graft-versus-host disease. Clin Exp Immunol (1990) 0.78
Murine monoclonal antibodies to DNA. A comparison of MRL/lpr NZB/W and chronically graft-versus-host-diseased mice. Clin Exp Immunol (1990) 0.78
Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis. Am J Pathol (1989) 0.77
Regulation of autoimmunity and donor cell engraftment by recipient Lyt-2+ cells during the graft-versus-host reaction. J Exp Med (1987) 0.75
Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference. Immunology (1993) 0.75
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature (1999) 5.77
Targeted inactivation of mouse RAD52 reduces homologous recombination but not resistance to ionizing radiation. Mol Cell Biol (1998) 2.93
A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol (1982) 2.74
Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity (1995) 2.40
TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today (1991) 2.06
Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J Exp Med (1983) 1.74
Changes in the V(H) gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor. Immunity (1997) 1.72
Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. J Exp Med (1983) 1.66
Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens? Transplant Rev (1976) 1.50
Chronic allogeneic disease. II. Development of lymphomas. J Exp Med (1970) 1.46
The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice. J Exp Med (1987) 1.39
Nickel allergy versus nickel tolerance: can oral uptake of nickel protect from sensitization? J Environ Monit (2004) 1.39
IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol (1991) 1.37
Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells. Immunol Rev (2000) 1.37
GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes (1998) 1.36
B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. Nat Immunol (2001) 1.33
Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today (1998) 1.30
Metal ion induced autoimmunity. Curr Opin Immunol (1995) 1.26
The role of chemokines in regulating cell migration during humoral immune responses. Cell (1999) 1.26
Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc Natl Acad Sci U S A (1989) 1.22
Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells. J Exp Med (1992) 1.20
Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation. J Immunol (1990) 1.16
Precursor B cells showing H chain allelic inclusion display allelic exclusion at the level of pre-B cell receptor surface expression. Immunity (1998) 1.16
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. V. High titers of IgG autoantibodies to double-stranded DNA. J Immunol (1981) 1.16
Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int Rev Immunol (2001) 1.15
Roles of IgH and L chains and of surrogate H and L chains in the development of cells of the B lymphocyte lineage. Annu Rev Immunol (1994) 1.15
Neutrophils and drug metabolism. Science (1995) 1.15
Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin. Diabetologia (2004) 1.15
Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. J Immunol (1983) 1.14
Immunologic induction of malignant lymphoma: genetic factors in the graft-versus-host model. J Natl Cancer Inst (1972) 1.14
Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med (1998) 1.12
Immunoblastic lymphadenopathy, systemic lupus erythematosus, and related disorders. Possible pathogenetic pathways. Am J Clin Pathol (1979) 1.10
B-cell development: a comparison between mouse and man. Immunol Today (1998) 1.09
Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD. J Immunol (1984) 1.09
Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis. J Exp Med (1972) 1.08
Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice. J Exp Med (1996) 1.06
Lineage commitment in lymphopoiesis. Curr Opin Immunol (2000) 1.06
Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease. J Immunol (1984) 1.05
Studies on the mechanism of drug sensitization: T-cell-dependent popliteal lymph node reaction to diphenylhydantoin. Clin Immunol Immunopathol (1981) 1.02
Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol (1997) 1.00
Immunological alterations inducible by mercury compounds. III. H-2A acts as an immune response and H-2E as an immune "suppression" locus for HgCl2-induced antinucleolar autoantibodies. Eur J Immunol (1989) 0.99
Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia (2000) 0.98
Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction. J Immunol (1985) 0.98
Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease. Clin Exp Immunol (1990) 0.97
Age-dependent changes in B lymphocyte development in man and mouse. Exp Gerontol (2000) 0.97
Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse. Blood (1995) 0.96
Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J Invest Dermatol (1985) 0.96
Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ Health Perspect (1996) 0.96
Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer. J Immunol (1986) 0.95
Immunological alterations inducible by mercury compounds. II. HgCl2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. Int Arch Allergy Appl Immunol (1989) 0.95
Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells. Blood (2001) 0.93
Immature B cells from human and mouse bone marrow can change their surface light chain expression. Eur J Immunol (1995) 0.92
An interleukin-6 transgene expressed in B lymphocyte lineage cells overcomes the T cell-dependent establishment of normal levels of switched immunoglobulin isotypes. Eur J Immunol (1995) 0.91
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. III. Autoantibodies to thymocytes. J Immunol (1981) 0.91
Mercuric-chloride-induced autoimmunity in mice involves up-regulated presentation by spleen cells of altered and unaltered nucleolar self antigen. Int Arch Allergy Immunol (1995) 0.90
Thymic stroma exposed to arylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation. J Immunol (1994) 0.90
Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides. Eur J Immunol (1996) 0.90
Three chemokines with potential functions in T lymphocyte-independent and -dependent B lymphocyte stimulation. Eur J Immunol (1999) 0.90
Murine systemic autoimmune disease induced by mercuric chloride: T helper cells reacting to self proteins. Int Arch Allergy Immunol (1996) 0.90
Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int Immunol (1996) 0.89
MHC control of IL-4-dependent enhancement of B cell Ia expression and Ig class switching in mice treated with mercuric chloride. Int Arch Allergy Immunol (1993) 0.89
Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E). Clin Exp Immunol (1986) 0.89
Cellular immunity in the mouse. IV. Altered thymic-dependent lymphocyte reactivity in the chronic graft vs host reaction and leukemia virus activation. Cell Immunol (1975) 0.89
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. IV. Autoantibodies to nuclear antigens. Clin Exp Immunol (1981) 0.89
Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Adv Exp Med Biol (1999) 0.89
Immunosuppression and malignant lymphomas in graft-versus-host reactions. Cancer Res (1973) 0.88
Immunopathological signs in mice treated with mercury compounds--I. Identification by the popliteal lymph node assay of responder and nonresponder strains. Int J Immunopharmacol (1988) 0.88
Cutaneous adverse reaction to ciprofloxacin: demonstration of specific lymphocyte proliferation and cross-reactivity to ofloxacin in vitro. Acta Derm Venereol (1997) 0.87
Over 95 per cent sensitization against allogeneic leukocytes following single massive blood transfusion. Vox Sang (1975) 0.87
Molecular characterization of the beta chain of the murine interleukin 5 receptor. Int Immunol (1991) 0.86
The induction of organ-specific antibodies during the graft-vs.-host reaction. Eur J Immunol (1988) 0.86
Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes. Eur J Immunol (1989) 0.86
3,3',4,4'-Tetrachlorobiphenyl inhibits proliferation of immature thymocytes in fetal thymus organ culture. Scand J Immunol (1994) 0.86
Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation. J Immunol (1983) 0.85
Nickel allergy in mice: enhanced sensitization capacity of nickel at higher oxidation states. J Immunol (1999) 0.85
Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells. J Exp Med (1984) 0.85
Intra-H-2 and T cell requirements for the induction of maximal positive and negative allogeneic effects in vitro. Eur J Immunol (1983) 0.85
Induction of graft versus host-associated immunodeficiency by CD4+ T cell clones. J Immunol (1990) 0.84
Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse. J Immunol (1987) 0.84
Predictive immunotoxicological test systems: suitability of the popliteal lymph node assay in mice and rats. Crit Rev Toxicol (1995) 0.84